| Literature DB >> 28832768 |
H Fang1, B Lu1, X Wang2, L Zheng2, K Sun2, W Cai1.
Abstract
This study proposed a decision tree model to screen upper urinary tract damage (UUTD) for patients with neurogenic bladder (NGB). Thirty-four NGB patients with UUTD were recruited in the case group, while 78 without UUTD were included in the control group. A decision tree method, classification and regression tree (CART), was then applied to develop the model in which UUTD was used as a dependent variable and history of urinary tract infections, bladder management, conservative treatment, and urodynamic findings were used as independent variables. The urethra function factor was found to be the primary screening information of patients and treated as the root node of the tree; Pabd max (maximum abdominal pressure, >14 cmH2O), Pves max (maximum intravesical pressure, ≤89 cmH2O), and gender (female) were also variables associated with UUTD. The accuracy of the proposed model was 84.8%, and the area under curve was 0.901 (95%CI=0.844-0.958), suggesting that the decision tree model might provide a new and convenient way to screen UUTD for NGB patients in both undeveloped and developing areas.Entities:
Mesh:
Year: 2017 PMID: 28832768 PMCID: PMC5561813 DOI: 10.1590/1414-431X20176638
Source DB: PubMed Journal: Braz J Med Biol Res ISSN: 0100-879X Impact factor: 2.590
Baseline characteristics of neurogenic bladder patients (NGB) with upper urinary tract damage (case group) or without it (control group).
| Characteristics | Case group (n=34) | Control group (n=78) | P |
|---|---|---|---|
| Age (years) | 49.9±18.6 | 45.2±14.6 | 0.15 |
| Gender (n, %) | 0.205 | ||
| Male | 17 (50%) | 49 (62.8%) | |
| Female | 17 (50%) | 29 (37.2%) | |
| NGB duration (days) | 7.5 (10.5) | 15 (604.25) | 0.023 |
| Urinary tract infection (n, %) | 0.005 | ||
| Yes | 13 (38.2%) | 52 (66.7%) | |
| No | 21 (61.8%) | 26 (33.3%) | |
| Conservative treatment (n, %) | 0.005 | ||
| No | 21 (61.8%) | 26 (33.3%) | |
| Bladder function/pelvic muscle exercise/pelvic electric | 13 (38.2%) | 52 (66.7%) | |
| stimulation therapy | |||
| Bladder management (n, %) | 0.106 | ||
| Urinate | 9 (26.4) | 18 (23) | |
| Indwelling catheter/cystostomy | 18 (52.9%) | 54 (69.2%) | |
| Clean intermittent catheterization | 7 (20.6%) | 6 (7.7%) | |
| Detrusor activity (n, %) | 0.016 | ||
| Normal | 21 (61.8%) | 29 (37.2%) | |
| Overactivity | 13 (38.2%) | 49 (62.8%) | |
| Bladder sensation (n, %) | 0.004 | ||
| Normal | 12 (35.3%) | 11 (14.1%) | |
| Increased | 10 (29.4%) | 14 (17.9%) | |
| Reduced/Absent | 12 (35.3%) | 53 (67.9%) | |
| Bladder capacity (n, %) | 0.004 | ||
| Normal | 12 (35.3%) | 8 (10.3%) | |
| High | 10 (29.4%) | 24 (30.8%) | |
| Low | 12 (35.3%) | 46 (59%) | |
| Urethra function (n, %) | <0.001 | ||
| Normal | 34 (100%) | 40 (51.3%) | |
| Incompetent | 0 (0%) | 38 (48.7%) | |
| Detrusor contractility (n, %) | 0.014 | ||
| Normal | 7 (20.6%) | 10 (12.8%) | |
| Underactive | 9 (26.5%) | 44 (56.4%) | |
| Acontractile | 18 (52.9%) | 24 (30.8%) | |
| Bladder outlet obstruction (n, %) | <0.001 | ||
| No | 27 (79.4%) | 34 (43.6%) | |
| Yes | 7 (20.6%) | 44 (56.4%) | |
| Bladder compliance (n, %) | 0.002 | ||
| ≥20 cmH2O | 15 (44.1%) | 58 (74.4%) | |
| <20 cmH2O | 19 (55.9%) | 20 (25.6%) | |
| Maximal bladder capacity (n, %) | 0.043 | ||
| ≥600 cmH2O | 10 (29.4%) | 39 (50%) | |
| <600 cmH2O | 24 (70.6%) | 39 (50%) | |
| Pdet max in filling phase (n, %) | <0.001 | ||
| ≤40 cmH2O | 22 (64.7%) | 15 (19.2%) | |
| >40 cmH2O | 12 (35.3%) | 63 (80.8%) | |
| Micturitional Pdet max (n, %) | <0.001 | ||
| ≤40 cmH2O | 16 (47.1%) | 11 (14.1%) | |
| >40 cmH2O | 18 (52.9%) | 67 (85.9%) | |
| Pves max in filling phase | 74.14±31.45 | 74.46±35.29 | 0.964 |
| Pabd max in filling phase | 26.08±11.67 | 20.57±13.13 | 0.037 |
Data are reported as means±SD or number and percentages. Pdet max: maximum detrusor pressure; Pabd max: maximum abdominal pressure; Pves max: maximum intravesical pressure. Data were analyzed with the t-test or chi-square test.
Figure 1.Decision tree model for risk of upper urinary tract damage (UUTD) in patients with neurogenic bladder. Pabd max: maximum abdominal pressure (>14 cmH2O); Pves max (maximum intravesical pressure, ≤89 cmH2O),
Classification rules of the decision tree model for risk of upper urinary tract damage (UUTD).
| Rules | Conditions | Risk of UUTD | n | |||
|---|---|---|---|---|---|---|
| Urethra function | Pabd max | Pves max | Gender | |||
| 1 | Normal | >14 | ≤89 | - | 79.2% | 19 |
| 2 | Normal | >14 | >89 | Female | 58.8% | 10 |
Pabd max: maximum abdominal pressure; Pves max: maximum intravesical pressure.
Results of the decision tree model evaluation.
| Evaluation measures | ||||||
|---|---|---|---|---|---|---|
| AUC | Sensitivity | Specificity | PV+ | PV- | Accuracy | |
| Results | 0.901 | 85.3% | 84.6% | 70.7% | 92.9% | 84.8% |
AUC: area under the curve; PV+: positive predictive value; PV-: negative predictive value.
Figure 2.Receiver operating characteristic analysis of the model, where the ROC curve is displayed in blue, and the reference is displayed in green.
Result of cross validation.
| Method | Estimate | Standard error |
|---|---|---|
| Resubstitution | 0.152 | 0.034 |
| Cross-Validation | 0.232 | 0.040 |